Trends in reproductive health in Israel: Implications for environmental health policy

Israel Journal of Health Policy Research

Volumn 1, Issue 1, 2012, Pages

  Berman, Tamar ^a   Levine, Hagai ^b   Gamzu, Ronni ^a   Grotto, Itamar ^a,c  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Epidemiology; Exposure; Fertility; Health policy; Reproduction; Surveillance; Trends

Indexed keywords

ENDOCRINE DISRUPTOR;

ARTICLE; CHEMICAL ACCIDENT; ECOSYSTEM MONITORING; ENVIRONMENTAL HEALTH; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HYPOSPADIAS; ISRAEL; MALE INFERTILITY; MENARCHE; PUBLIC HEALTH PROBLEM; REPRODUCTIVE HEALTH; SPERM QUALITY; TESTIS CANCER;

EID: 84880944302     PISSN: None     EISSN: 20454015     Source Type: Journal    
DOI: 10.1186/2045-4015-1-34     Document Type: Article

References (44)

1. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993, 101(5):378-384. 10.1289/ehp.93101378, 1519860, 8080506.
2. Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller T, Gore AC. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr Rev 2009, 30(4):293-342. 10.1210/er.2009-0002, 2726844, 19502515.
3. de Mouzon J, Lancaster P, Nygren KG, Sullivan E, Zegers-Hochschild F, Mansour R, Ishihara O, Adamson D, International Committee for Monitoring Assisted Reproductive Technology World Collaborative Report on Assisted Reproductive Technology, 2002. Hum Reprod 2009, 24:2310-2320. International Committee for Monitoring Assisted Reproductive Technology.
4. Bar-Chana M. Israel National Cancer Registry, Cancer Incidence Tables 2010, http://www.health.gov.il/download/sartan/trends/Testis.pdf.
5. Beri A, Matzkin H, Liphshitz I, Barchana M. Epidemiological characteristics and trends of testicular cancer in Israel 1992-2002. Harefuah 2007, 146(7):515-519. 575 [Hebrew].
6. Bar-Chana M. Israel National Cancer Registry, Cancer Incidence Tables 2010, http://www.health.gov.il/download/sartan/trends/Breast.pdf.
7. International Clearinghouse for Birth Defects Annual Report 2010, http://www.icbdsr.org/filebank/documents/ar2005/Report2010.pdf, International Clearinghouse for Birth Defects.
8. Rubin L. Undescended Testes and Hypospadias in Israel 2000-2008 2009, Presentation at Conference on Reproductive Health and Estrogenic and anti-androgenic Chemicals, Tel Aviv, Israel.
9. Dor J, Homburg R, Rabau E. An evaluation of etiologic factors and therapy in 665 infertile couples. Fertil Steril 1977, 28(7):718-722.
10. Farhi J, Ben-Haroush A. Distribution of causes of infertility in patients attending primary fertility clinics in Israel. Isr Med Assoc J 2011, 13(1):51-54.
11. Sella T, Chodick G, Lunenfeld E, Shalev V. Further evidence on the high prevalence of male factor infertility diagnosis in Israel. Isr Med Assoc J 2011, 13(6):386.
12. Almagor M, Ivnitzki I, Yaffe H, Baras M. Changes in semen quality in Jerusalem between 1990 and 2000: A cross-sectional and longitudinal study. Arch Andrology 2003, 49(2):139-144.
13. Benshushan A, Shoshani O, Paltiel O, Schenker J, Lewin A. Is there really a decrease in sperm parameters among health young men? A survey of sperm donation during 15 years. J Assist Reprod Genet 1997, 14(6):347-353. 10.1007/BF02765840, 9226515.
14. Haimov-Kochman R, Har-Nir R, Ein-Mor E, Ben-Shoshan V, Greenfield C, Eldar I, Bdolah Y, Hurwitz A. Is The Quality of Donated Semen Deteriorating? Findings from a 15 Year Longitudinal Analysis of Weekly Sperm Samples. Isr Med Assoc J 2012, 14:372-377.
15. Chodick G, Huerta M, Balicer RD, Davidovitch N, Grotto I. Secular trends in age at menarche, smoking, and oral contraceptive use among Israeli girls. Prev Chronic Dis 2005, 2(2):A12. 1459462, 16263045.
16. Neumark YD, Grotto I, Kark JD. Twenty-year trends in illicit drug use among young Israelis completing military duty. Addiction 2004, 99(5):641-648. 10.1111/j.1360-0443.2004.00716.x, 15078239.
17. Gross R, Brammli-Greenberg S, Rabinowitz J, Gordon B, Afek A. Disparities in obesity temporal trends of Israeli adolescents by ethnic origin. Int J Pediatr Obes 2011, 6(2-2):e154-e161.
18. Rosen B, Merkur S. Israel: Health system review. Health Systems in Transition 2009, 1-226. World Health Organization, Merker S.
19. Berger-Achituv S, Shohat T, Romano-Zelekha O, Ophir E, Rachmani S, Malovizky D, Garty BZ. Widespread use of soy-based formula without clinical indications. J Pediatr Gastroenterol Nutr 2005, 41(5):660-666. 10.1097/01.mpg.0000181855.77488.bf, 16254527.
20. Fronczak CM, Kim ED, Barqawi AB. The Insults of Recreational Drug Abuse on Male Fertility. J Androl 2011, 10.2164/jandrol.110.011874 [Epub ahead of print].
21. Gaudineau A, Ehlinger V, Vayssiere C, Jouret B, Arnaud C, Godeau E. Factors associated with early menarche: results from the French Health Behaviour in School-aged Children (HBSC) study. BMC Publ Health 2010, 10:175.
22. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003, 170(1):5-11. 10.1097/01.ju.0000053866.68623.da, 12796635.
23. Huyghe E, Plante P, Thonneau PF. Testicular cancer variations in time and space in Europe. Eur Urol 2007, 51(3):621-628. 10.1016/j.eururo.2006.08.024, 16963178.
24. Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sørensen TI, Dunkel L, Himes JH, Teilmann G, Swan SH. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 2008, 121(S3):S172-S191.
25. Aksglaede L, Sørensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 2009, 123(5):e932-e939. 10.1542/peds.2008-2491, 19403485.
26. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for deacreasing quality of semen during past 50 years. BMJ 1992, 305(6854):609-613. 10.1136/bmj.305.6854.609, 1883354, 1393072.
27. Swan S, Elkin E, Fenster L. The Question of Declining Sperm Density Revisited: An Analysis of 101 Studies Published 1934-1996. Environ Health Perspect 2000, 108(10):961-966. 10.1289/ehp.00108961, 1240129, 11049816.
28. Merzenich H, Zeeb H, Blettner M. Decreasing sperm quality: a global problem?. BMC Publ Health 2010, 10:24.
29. Andersson AM, Jørgensen N, Main KM, Toppari J, Rajpert De-Meyts E, Leffers H, Juul A, Jensen TK, Skakkebæk NE. Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl 2008, 31:74-80. 10.1111/j.1365-2605.2007.00853.x, 2440492, 18194282.
30. European Workshop on the impact of endocrine disruptors on human health and wildlife. http://ec.europa.eu/environment/endocrine/documents/reports_conclusions_en.htm, European Workshop on the impact of endocrine disruptors on human health and wildlife.
31. Community Strategy for Endocrine Disruptors http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:1999:0706:FIN:EN:PDF, Community Strategy for Endocrine Disruptors.
32. 4th Report on the implementation of the "Community Strategy for Endocrine Disrupters" a range of substances suspected of interfering with the hormone systems of humans and wildlife http://ec.europa.eu/environment/endocrine/documents/sec_2011_1001_en.pdf.
33. Endocrine Disruptor Screening Program Statement of Policy, http://www.epa.gov/endo/pubs/122898frnotice.pdf, Endocrine Disruptor Screening Program.
34. Vogel J. Perils of paradigm: Complexity, policy design, and the Endocrine Disruptor Screening Program. Environmental Health: A Global Access Science Source 2005, 4:2.
35. Consumer Product Safety Improvement Act of 2008 http://www.cpsc.gov/cpsia.pdf.
36. Bisphenol A, BPA Use in Food Contact Application http://www.fda.gov/newsevents/publichealthfocus/ucm064437.htm, BPA.
37. Centers for Disease Control National Report on Human Exposure to Environmental Chemicals National Report on Human Exposure to Environmental Chemicals, http://www.cdc.gov/exposurereport/, Centers for Disease Control.
38. Berman T, Amitai Y, Almog S, Richter ED. Human biomonitoring in Israel: Past, present, future. Int J Hyg Environ Health 2012, 215(2):138-141. 10.1016/j.ijheh.2011.09.006, 22218107.
39. Food and Drug Administration Draft Assessment of Bisphenol A for Use in Food Contact Applications 2008, http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-0038b1_01_02_FDA%20BPA%20Draft%20Assessment.pdf, Food and Drug Administration.
40. European Commission Health and Consumer Protection Directorate General Opinion of the Scientific Committee on Food on Bisphenol A 2002, http://ec.europa.eu/food/fs/sc/scf/out128_en.pdf, European Commission Health and Consumer Protection Directorate General.
41. Vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ, Hauser R, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Keri RA, Knudsen KE, Laufer H, LeBlanc GA, Marcus M, McLachian JA, Myers JP, Nadal A, Newbold RR, Olea N, Prins GS, Richter C, Rubin BS, Sonnenschein C, Soto AM, et al. Chapel Hill Bisphenol A Expert Panel Consensus Statement: Integrations of mechanism, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007, 24(2):131-138. 10.1016/j.reprotox.2007.07.005, 2967230, 17768031.
42. Communication from the commission on the precautionary principle, http://eurlex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&numdoc=52000DC0001&lg=en
43. Wier E, Schabas R, Wilson K, Mackie C. A Canadian Framework for Applying the Precautionary Principle to Public Health Issues. Can J Public Health 2010, 101(5):396-398.
44. Agreement on the application of sanitary and phytosanitary measures, http://www.wto.org/english/docs_e/legal_e/15-sps.pdf.